全文获取类型
收费全文 | 11312篇 |
免费 | 690篇 |
国内免费 | 82篇 |
专业分类
耳鼻咽喉 | 80篇 |
儿科学 | 235篇 |
妇产科学 | 248篇 |
基础医学 | 1609篇 |
口腔科学 | 223篇 |
临床医学 | 775篇 |
内科学 | 2790篇 |
皮肤病学 | 322篇 |
神经病学 | 762篇 |
特种医学 | 390篇 |
外科学 | 1686篇 |
综合类 | 35篇 |
一般理论 | 3篇 |
预防医学 | 457篇 |
眼科学 | 219篇 |
药学 | 828篇 |
中国医学 | 33篇 |
肿瘤学 | 1389篇 |
出版年
2023年 | 89篇 |
2022年 | 227篇 |
2021年 | 345篇 |
2020年 | 202篇 |
2019年 | 236篇 |
2018年 | 288篇 |
2017年 | 248篇 |
2016年 | 274篇 |
2015年 | 334篇 |
2014年 | 341篇 |
2013年 | 425篇 |
2012年 | 684篇 |
2011年 | 666篇 |
2010年 | 377篇 |
2009年 | 295篇 |
2008年 | 561篇 |
2007年 | 528篇 |
2006年 | 519篇 |
2005年 | 539篇 |
2004年 | 461篇 |
2003年 | 467篇 |
2002年 | 413篇 |
2001年 | 296篇 |
2000年 | 290篇 |
1999年 | 247篇 |
1998年 | 134篇 |
1997年 | 114篇 |
1996年 | 92篇 |
1995年 | 74篇 |
1994年 | 49篇 |
1993年 | 51篇 |
1992年 | 184篇 |
1991年 | 162篇 |
1990年 | 160篇 |
1989年 | 207篇 |
1988年 | 195篇 |
1987年 | 172篇 |
1986年 | 155篇 |
1985年 | 143篇 |
1984年 | 94篇 |
1983年 | 74篇 |
1982年 | 45篇 |
1981年 | 45篇 |
1979年 | 77篇 |
1978年 | 62篇 |
1977年 | 39篇 |
1976年 | 40篇 |
1974年 | 47篇 |
1973年 | 37篇 |
1972年 | 37篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
91.
This review describes the historical development of aesthetic surgery in Japan and parallels with the development of the
specialty in the United States. The focus is on the consequences of aesthetic surgery in the male patient when collaboration
between mental health clinicians and surgeons lags. The cultural, social, and psychological issues raised are relevant to
the diverse cultural groups now seeking aesthetic surgery in the United States. Case illustrations are a reminder to aesthetic
surgeons of the potential need for more comprehensive evaluation in the group of male patients who may be at added risk for
negative outcomes in terms of satisfaction. 相似文献
92.
Matthias Grube Katayoun Rezvani Adrian Wiestner Hiroshi Fujiwara Giuseppe Sconocchia Jan J Melenhorst Nancy Hensel Gerald E Marti Larry W Kwak Wyndham Wilson John A Barrett 《Clinical cancer research》2004,10(3):1047-1056
PURPOSE: To investigate potential immunotherapeutic strategies in B lymphocytic malignancies we looked for CTLs recognizing CD19 and CD20 epitopes. EXPERIMENTAL DESIGN: Three CD19 and CD20 peptides binding to HLA-A*0201 were identified and used to detect peptide specific CTLs by a quantitative real-time PCR to measure IFN-gamma mRNA expression in 23 healthy individuals and 28 patients (18 chronic lymphocytic leukemia (CLL), 7 follicular lymphoma, 2 acute lymphocytic leukemia, and 1 large cell lymphoma). Peptide-specific CTLs were expanded in culture with CD40-activated B cells to test lytic activity in three patients. RESULTS: In healthy individuals, CD8+ T-cell responses were detected in one to CD19(74-82), in three to CD20(127-135), and three to CD20(188-196). Seven of 27 patients (6 with CLL) had CD8+ T cells recognizing CD19(74-82). Seven patients responded to CD20(127-135) and three to CD20(188-196). All were CLL patients. CD19(74-82)-specific CTLs from three patients were expanded over 4 weeks. These cells were HLA-A*0201 specific and lytic for peptide-loaded antigen-presenting cells but not to malignant or unpulsed B cells. CONCLUSIONS: CTLs that recognize CD19 and CD20 epitopes exist in healthy individuals and may be increased in CLL patients. They are of low avidity and require high doses of peptide for activation. Strategies to increase T-cell avidity would be necessary for T-cell immunotherapeutic approaches using the peptides studied. 相似文献
93.
94.
Murakami T Kikugawa D Endou K Fukuhiro Y Ishida A Morita I Masaki H Inada H Fujiwara T 《Artificial organs》2000,24(12):953-958
In this study, we analyzed the extent and pattern of regression of left ventricular (LV) hypertrophy after aortic valve replacement in patients with aortic stenosis (AS) and compared the results with those of another group of patients with aortic regurgitation (AR). Seventy patients who underwent isolated aortic valve replacement were divided into 2 groups. Group 1 was comprised of 29 patients who underwent aortic valve replacement for aortic stenosis, and Group 2 of 41 patients who underwent aortic valve replacement for aortic regurgitation. A third group of 10 healthy subjects served as a healthy control group. Echocardiographic studies were done before the operation and 5 years postoperatively. At follow-up, a significant reduction in the left ventricular mass was found in both groups, but it remained significantly greater than in the healthy control group. The ratio of LV wall thickness to radius (th/r) in Group 1 decreased significantly, and at follow-up it was within the normal value. In Group 2, the th/r ratio increased, and at follow-up it was within the normal value. After aortic valve replacement, the wall thickness remained significantly greater than normal for patients with AS, and the chamber radius remained significantly greater than normal for patients with AR. For these reasons, LV hypertrophy still existed in both groups at postoperative follow-up. The actuarial survival rate was 85.3% at 16 years for Group 1 and 83.4% at 18 years for Group 2. There was no significant difference in the long-term survival rates between the 2 groups. Actuarial freedom from valve-related events was 91.9% at 16 years for Group 1 and 82% at 18 years for Group 2. There was no significant difference in the valve-related event free curves between groups. After 5 years of follow-up, th/r reached normal for both groups, indicating remodeling of the LV geometry after aortic valve replacement. 相似文献
95.
Expression level of valosin-containing protein is strongly associated with progression and prognosis of gastric carcinoma. 总被引:9,自引:0,他引:9
Shinji Yamamoto Yasuhiko Tomita Yoshihiko Hoshida Shuji Takiguchi Yoshiyuki Fujiwara Takushi Yasuda Masahiko Yano Shoji Nakamori Masato Sakon Morito Monden Katsuyuki Aozasa 《Journal of clinical oncology》2003,21(13):2537-2544
PURPOSE: Valosin-containing protein (VCP; also known as p97) was shown to be associated with antiapoptotic function and metastasis via activation of nuclear factor kappa-B signaling pathway. In this study, association of VCP expression with recurrence of gastric carcinoma (GC), in which lymphatic vessels are the main route of spread, was examined. PATIENTS AND METHODS: VCP expression in 330 patients with GC (242 males and 88 females) with ages ranging from 26 to 81 years (median, 60 years) was analyzed by immunohistochemistry, in which staining intensity in tumor cells was categorized as weaker (level 1) or equal to or stronger (level 2) than that in endothelial cells. RESULTS: Ninety-four (28.7%) patient cases showed level 1 and 233 patient cases (71.3%) showed level 2 VCP expression. Patients with level 2 expression showed higher rates of large tumor size (P <.0001), undifferentiated histologic subtype (P <.05), presence of vascular and lymphatic invasion (P <.0001 for both), presence of lymph node metastasis (P <.0001), deep tumor invasion (P <.0001), and poorer disease-free and overall survivals (P <.0001 for both) compared with those with level 1 VCP expression. Multivariate analysis revealed VCP expression level as an independent prognosticator for disease-free and overall survival. VCP level was an indicator for disease-free and overall survival in the early (pT1; P <.01 and P <.05, respectively) and advanced (pT2-4; P <.05 for both) group of pathologic tumor-node-metastasis system classification. CONCLUSION: The prognostic significance of VCP expression level in GC was demonstrated. 相似文献
96.
Reduced MLH1 expression after chemotherapy is an indicator for poor prognosis in esophageal cancers.
Kentaro Kishi Yuichiro Doki Masahiko Yano Takushi Yasuda Yoshiyuki Fujiwara Syuji Takiguchi Sontae Kim Ichiro Higuchi Morito Monden 《Clinical cancer research》2003,9(12):4368-4375
PURPOSE: Loss of function or expression of the mismatch repair gene MLH1 has been implicated in experimentally acquired resistance to cisplatin (CDDP) and other anticancer agents. The clinical significance of MLH1 expression was evaluated in advanced thoracic squamous cell carcinoma of the esophagus (ESCC) treated by neoadjuvant chemotherapy. EXPERIMENTAL DESIGN: We investigated MLH1 and P53 expression by immunohistochemistry in the surgical specimens of 107 patients who had undergone preoperative chemotherapy using CDDP along with 5-FU and ADM. These findings were correlated with the clinical outcome for this treatment. Biopsy samples before chemotherapy in 20 of these patients, and another 43 surgical specimens without chemotherapy, were also examined as control samples. RESULTS: In surgical specimens of ESCC, low MLH1 expression was not frequent without chemotherapy, whereas it was commonly observed after chemotherapy (14 versus 37%, P = 0.0057). Comparison between samples before and after chemotherapy revealed that MLH1 expression was unchanged during chemotherapy in 12 of 20 patients (60%) but was from high to low in 8 of 20 patients (40%). In the surgical specimen after neoadjuvant chemotherapy, MLH1 expression was not correlated with any clinicopathological factors, including the response to chemotherapy. However, low MLH1 showed poorer prognosis than high MLH1 (5-year survival 40.6 versus 19.3%, P = 0.0393), and in multivariate analysis, MLH1 was an independent prognostic factor for this multimodal treatment, following lymph node metastasis and clinical response to chemotherapy. Positive p53 expression, which was not affected by chemotherapy, was weakly associated with a poor response and clinical outcome, although this trend was not significant. CONCLUSIONS: In advanced ESCC, expression of MLH1 is reduced during CDDP-based chemotherapy, and this may partly account for poor postoperative survival. 相似文献
97.
98.
99.
H. Nakamura M. Fujiwara M. Kawasaki N. Nonomura S. Takahashi 《European archives of oto-rhino-laryngology》1998,255(6):289-292
Changes in dividing cells of the olfactory epithelium from guinea pigs of different ages were examined by immunohistochemical
staining using anti-proliferating cell nuclear antigen antibody. Numerous dividing cells were scattered diffusely in the basal
layer of the olfactory epithelium at 1 and 2 months following birth and then gradually decreased with maturation until 4 months.
Findings then remained constant between 4 and 24 months. Subsequently, cell numbers were found to decrease as animals became
older. The number of olfactory receptor cells did not vary significantly between 1 and 30 months. Although no correlation
could be found between the numbers of dividing cells and olfactory receptor cells, it is still possible that the longevity
of the olfactory receptor cells changes to maintain the overall size of the neuronal population.
Received: 18 February 1998 / Accepted: 9 April 1998 相似文献
100.
Homotypic Adhesion through Carcinoembryonic Antigen Plays a Role in Hepatic Metastasis Development 总被引:2,自引:0,他引:2
Toshiaki Yoshioka Takashi Masuko Hitoshi Kotanagi Osamu Aizawa Yuri Saito Hiroshi Nakazato Kenji Koyama Yoshiyuki Hashimoto 《Cancer science》1998,89(2):177-185
We established a cell line with high metastatic potential to the liver (LS-LM4) after four successive repetitions of splenic injection of liver-metastatic cells in SCID mice. This cell line strongly expressed CEA and showed increased homotypic adhesion as compared with the parent cell line (LS174T). To examine the role of CEA in the increased homotypic adhesion, LS-LM4 cells were treated with anti-CEA antibody and subjected to an in vitro adhesion and aggregation assay. Further, to study the role of CEA in the hepatic metastasis of cells with high metastatic potential, LS-LM4 cells were treated with anti-CEA antibody, and the inhibition of hepatic metastasis after splenic injection in vivo was examined. There was a 62% decrease in the homotypic adhesion of anti-CEA antibody-treated (100 μg/ml) LS-LM4 cells under a Ca2+ -free condition as compared with the control ( P <0.01). Anti-CEA antibody (100 μg/ml) inhibited cell aggregation under a Ca2+ -free condition ( P <0.05). Treatment with anti-E-cadherin antibody (60 μ/ml) plus anti-CEA antibody (100 μg/ml) inhibited cell aggregation more potently than anti-E-cadherin antibody treatment alone in the presence of Ca2+ . In vivo , there was a 75% decrease in the number of hepatic metastatic nodules in the G125 anti-CEA antibody-treated group as compared with the control group ( P <0.01). Similarly, there was a 40% decrease in the diameter of metastatic nodules and there was a 90% decrease in total tumor volume of hepatic metastasis in the G125 anti-CEA antibody-treated group as compared with the control ( P <0.01). These results suggest that increased metastatic potential to the liver is at least partly due to increased homotypic binding mediated by CEA. 相似文献